These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34666689)

  • 1. Anti-hypertensive drugs deprescribing: an updated systematic review of clinical trials.
    Crisafulli S; Luxi N; Coppini R; Capuano A; Scavone C; Zinzi A; Vecchi S; Onder G; Sultana J; Trifirò G
    BMC Fam Pract; 2021 Oct; 22(1):208. PubMed ID: 34666689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review of randomised-controlled trials on deprescribing outcomes in older adults with polypharmacy.
    Omuya H; Nickel C; Wilson P; Chewning B
    Int J Pharm Pract; 2023 Jun; 31(4):349-368. PubMed ID: 37155330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Deprescribing Interventions in Older Hospitalised Patients on Prescribing and Clinical Outcomes: A Systematic Review of Randomised Trials.
    Thillainadesan J; Gnjidic D; Green S; Hilmer SN
    Drugs Aging; 2018 Apr; 35(4):303-319. PubMed ID: 29541966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of deprescribing interventions on mortality and health outcomes in older people: An updated systematic review and meta-analysis.
    Quek HW; Page A; Lee K; Lee G; Hawthorne D; Clifford R; Potter K; Etherton-Beer C
    Br J Clin Pharmacol; 2024 Oct; 90(10):2409-2482. PubMed ID: 39164070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies for Identifying Patients for Deprescribing of Blood Pressure Medications in Routine Practice: An Evidence Review.
    Sheppard JP; Benetos A; Bogaerts J; Gnjidic D; McManus RJ
    Curr Hypertens Rep; 2024 May; 26(5):225-236. PubMed ID: 38305846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OPtimising Treatment for MIld Systolic hypertension in the Elderly (OPTiMISE): protocol for a randomised controlled non-inferiority trial.
    Sheppard JP; Burt J; Lown M; Temple E; Benson J; Ford GA; Heneghan C; Hobbs FDR; Jowett S; Little P; Mant J; Mollison J; Nickless A; Ogburn E; Payne R; Williams M; Yu LM; McManus RJ
    BMJ Open; 2018 Oct; 8(9):e022930. PubMed ID: 30287610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What do older adults with multimorbidity and polypharmacy think about deprescribing? The LESS study - a primary care-based survey.
    Rozsnyai Z; Jungo KT; Reeve E; Poortvliet RKE; Rodondi N; Gussekloo J; Streit S
    BMC Geriatr; 2020 Oct; 20(1):435. PubMed ID: 33129274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deprescribing in multi-morbid older people with polypharmacy: agreement between STOPPFrail explicit criteria and gold standard deprescribing using 100 standardized clinical cases.
    Curtin D; Dukelow T; James K; O'Donnell D; O'Mahony D; Gallagher P
    Eur J Clin Pharmacol; 2019 Mar; 75(3):427-432. PubMed ID: 30421220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evidence database for deprescribing of antipsychotic drugs in elderly and senile patients].
    Tkacheva ON; Ostroumova OD; Krasnov GS; Isaev RI; Kotovskaya YV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(5):162-172. PubMed ID: 31317906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes in deprescribing implementation trials and compliance with expert recommendations: a systematic review.
    Nizet P; Evin A; Brociero E; Vigneau CV; Huon JF
    BMC Geriatr; 2023 Jul; 23(1):428. PubMed ID: 37438697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted Deprescribing in an Outpatient Hemodialysis Unit: A Quality Improvement Study to Decrease Polypharmacy.
    McIntyre C; McQuillan R; Bell C; Battistella M
    Am J Kidney Dis; 2017 Nov; 70(5):611-618. PubMed ID: 28416321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers and enablers for deprescribing among older, multimorbid patients with polypharmacy: an explorative study from Switzerland.
    Zechmann S; Trueb C; Valeri F; Streit S; Senn O; Neuner-Jehle S
    BMC Fam Pract; 2019 May; 20(1):64. PubMed ID: 31088397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measuring Quality of Life in Deprescribing Trials: A Scoping Review.
    Thompson W; Lundby C; Bleik A; Waring H; Hong JA; Xi C; Hughes C; Salzwedel DM; McDonald EG; Pruskowski J; Scott S; Spinewine A; Kutner JS; Graabæk T; Elmi S; Moriarty F
    Drugs Aging; 2024 May; 41(5):379-397. PubMed ID: 38709466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits and Harms of Deprescribing Antihyperglycemics for Adults With Type 2 Diabetes: A Systematic Review.
    Deng Z; Thompson W; Korenvain C; Lega IC; Farrell B; Lochnan H; McCarthy LM
    Can J Diabetes; 2022 Jul; 46(5):473-479. PubMed ID: 35739041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nursing home team-care deprescribing study: a stepped-wedge randomised controlled trial protocol.
    Kua CH; Yeo CYY; Char CWT; Tan CWY; Tan PC; Mak VS; Lee SWH; Leong IY
    BMJ Open; 2017 May; 7(5):e015293. PubMed ID: 28490560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a patient-centred deprescribing procedure in older multimorbid patients in Swiss primary care - A cluster-randomised clinical trial.
    Zechmann S; Senn O; Valeri F; Essig S; Merlo C; Rosemann T; Neuner-Jehle S
    BMC Geriatr; 2020 Nov; 20(1):471. PubMed ID: 33198634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient values and preferences on polypharmacy and deprescribing: a scoping review.
    Forest E; Ireland M; Yakandawala U; Cavett T; Raman-Wilms L; Falk J; McMillan D; Linthorst R; Kosowan L; Labine L; Leong C
    Int J Clin Pharm; 2021 Dec; 43(6):1461-1499. PubMed ID: 34550540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel tool for deprescribing in chronic patients with multimorbidity: List of Evidence-Based Deprescribing for Chronic Patients criteria.
    Rodríguez-Pérez A; Alfaro-Lara ER; Albiñana-Perez S; Nieto-Martín MD; Díez-Manglano J; Pérez-Guerrero C; Santos-Ramos B
    Geriatr Gerontol Int; 2017 Nov; 17(11):2200-2207. PubMed ID: 28544188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.